ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -41.4% | -52.8% | +168.6% | +104.6% | +16.2% | -55.1% | +70.5% | -53.2% | -91.9% | +73.8% | +77.1% | |
| – | -48.4% | -73.7% | +2,393.9% | +105.4% | +14.6% | -55.1% | +67.9% | -53.7% | -92.3% | +92.2% | +77.1% | |
| – | -45.4% | -75.7% | +2,878.6% | +101.4% | -53.7% | +9.7% | +72.2% | -54.3% | -94.2% | -90.2% | +4,216.2% | |
| – | -45.4% | -75.7% | +2,878.6% | +101.4% | +15.8% | -56.1% | +72.2% | -54.3% | -94.2% | -90.2% | +4,216.2% | |
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | |
| – | -58.4% | – | – | – | – | – | – | – | – | – | – | |
| – | -18.2% | -17.3% | – | – | – | – | – | – | – | – | – | |
| – | +25.3% | -36.3% | -26.6% | +128.1% | +191.2% | -28.5% | +40.1% | +39.7% | -23.5% | +12.3% | -37.1% | |
| – | -57.3% | -52.6% | +827.7% | +128.1% | +51.2% | -16.7% | +1.2% | +132.0% | -1.7% | +20.3% | -37.1% | |
| – | – | – | – | – | – | +16.4% | -88.3% | +614.2% | -49.9% | +177.2% | -84.7% | |
| – | – | – | – | -51.2% | +150.5% | -74.3% | +186.7% | +119.0% | +88.7% | -6.2% | -49.3% | |
| – | – | – | – | – | – | – | – | – | -81.2% | – | – | |
| – | -55.5% | -62.7% | +368.4% | +100.9% | -15.6% | -71.8% | +118.8% | -147.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +163.2% | +41.0% | +389.8% | +551.9% | +17.3% | +5.4% | +74.4% | +23.9% | +18.7% | +46.2% | +228.5% |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.